We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.73B
AUM Growth
+$291M
Cap. Flow
-$854M
Cap. Flow %
-14.91%
Top 10 Hldgs %
13.11%
Holding
1,633
New
425
Increased
192
Reduced
104
Closed
544

Top Buys

Rank Stock Value
1
NOK icon
Nokia
NOK
+$38.3M
2
CACC icon
Credit Acceptance
CACC
+$34.3M
3
PYPL icon
PayPal
PYPL
+$30.4M
4
XOM icon
ExxonMobil
XOM
+$29.8M
5
TEAM icon
Atlassian
TEAM
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 15.02%
2 Financials 14.93%
3 Energy 5.43%
4 Utilities 5.37%
5 Healthcare 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWVLW icon
1026
Swvl Holdings Corp Warrant
SWVLW
$136K
$6.85K ﹤0.01%
2,000
-48,000
-96% -$1.01K
BTWNW
1027
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$6.17K ﹤0.01%
50,000
IMDX
1028
Insight Molecular Diagnostics
IMDX
$152M
$3.21K ﹤0.01%
500
-1,073
-68% -$11.8K
CCV.WS
1029
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$2.02K ﹤0.01%
25,000
SDSTW
1030
Stardust Power Inc Warrant
SDSTW
$4.56M
$875 ﹤0.01%
29,166
CSSEL
1031
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Warrant
CSSEL
$225 ﹤0.01%
12,300
KALWW
1032
DELISTED
Kalera Public Limited Company Warrant
KALWW
$155 ﹤0.01%
21
-212,479
-100% -$7.84K
AA icon
1033
Alcoa
AA
$11.6B
-6,351
Closed -$214K
AAPL icon
1034
Apple
AAPL
$4.95T
-61,935
Closed -$8.56M
ABBV icon
1035
AbbVie
ABBV
$454B
-3,283
Closed -$441K
ABOS icon
1036
Acumen Pharmaceuticals
ABOS
$159M
-10,092
Closed -$101K
ACTG icon
1037
Acacia Research
ACTG
$447M
-17,487
Closed -$71K
ADT icon
1038
ADT
ADT
$5.24B
-759,706
Closed -$5.69M
ADVM
1039
DELISTED
Adverum Biotechnologies
ADVM
-3,099
Closed -$29K
AGNC icon
1040
AGNC Investment
AGNC
$12.4B
-58,953
Closed -$496K
AKBA icon
1041
Akebia Therapeutics
AKBA
$343M
-64,849
Closed -$21K
ALE
1042
DELISTED
Allete
ALE
-20,000
Closed -$1M
ALLK
1043
DELISTED
Allakos
ALLK
-12,654
Closed -$77K
ALLR
1044
Allarity Therapeutics
ALLR
$19.6M
0
-$51K
ALNY icon
1045
Alnylam Pharmaceuticals
ALNY
$37.2B
-4,107
Closed -$822K
ALT icon
1046
Altimmune
ALT
$576M
-14,139
Closed -$181K
ALTI icon
1047
AlTi Global
ALTI
$402M
-300,000
Closed -$2.97M
AMD icon
1048
Advanced Micro Devices
AMD
$807B
-114,766
Closed -$7.27M
AMGN icon
1049
Amgen
AMGN
$203B
-5,106
Closed -$1.15M
AN icon
1050
AutoNation
AN
$7.1B
-2,848
Closed -$290K

Similar funds

LMR Partners's Q4 2022 Portfolio in Review

As of Q4 2022, LMR Partners held 1,633 positions worth $5.73B, up 5.4% from $5.44B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

LMR Partners withdrew a net $854M in Q4 2022, closing 544 positions and reducing 104 holdings. Its most notable exit was Marvell Technology, an estimated $33.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Energy.

Against the trend, LMR Partners opened a new position in PayPal worth $27M.

  • LMR Partners's largest Q4 2022 buy was PayPal: 379,562 shares worth $27M.
  • LMR Partners added most to Nokia in Q4 2022, an estimated $38.3M increase.
  • LMR Partners's biggest Q4 2022 reduction was Wells Fargo, cutting an estimated $54.3M.
  • LMR Partners fully exited Marvell Technology in Q4 2022, selling an estimated $33.3M.
  • LMR Partners's ten largest holdings make up 13% of its $5.73B portfolio in Q4 2022.
  • LMR Partners opened 425 new positions and closed 544 in Q4 2022.
  • LMR Partners's portfolio value rose 5.4% quarter-over-quarter to $5.73B.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.